ArticleFrontiers in pharmacology2022

Risk of major adverse events associated with gabapentinoid and opioid combination therapy: A systematic review and meta-analysis.

Jongsung Hahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.